Changes in depression subtypes for women during treatment with citalopram: a latent transition analysis

Archives of Women's Mental Health
Christine M UlbrichtKate L Lapane

Abstract

The aim of this study was to characterize latent subtypes of major depression and changes in these subtypes among women receiving citalopram in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial. Latent transition analysis was applied to data from 755 women who completed baseline and week 12 study visits in level 1 of STAR*D. Items from the self-report version of the Quick Inventory of Depressive Symptomatology were used as indicators of latent depression subtype. Four subtypes were identified at baseline and week 12. The baseline subtypes were Mild (21 %), Moderate (30 %), Severe with Increased Appetite (16 %), and Severe with Decreased Appetite (34 %). The subtypes at week 12 were Symptom Resolution (65 %), Mild (23 %), Moderate (9 %), and Severe with Psychomotor Disturbances (3 %). Women in the Moderate subtype at baseline had the greatest chance of moving to Symptom Resolution (87 %). Women in the Severe with Decreased Appetite subtype had the lowest chance of transitioning to Symptom Resolution (46 %). Depression severity and appetite distinguished depression subtypes for women before treatment with citalopram. Depression severity and psychomotor disturbances characterized the subtypes after treatmen...Continue Reading

References

Jan 1, 1986·Psychotherapy and Psychosomatics·I Marks
Jun 4, 2002·The American Journal of Psychiatry·Brett Silverstein
Dec 17, 2002·Journal of Psychiatric Research·Maurice M Ohayon, Thomas Roth
May 21, 2003·The Journal of Clinical Psychiatry·Matthew MenzaRachel Sokol Opper
Feb 3, 2004·The American Journal of Psychiatry·Maria A OquendoJ John Mann
Apr 6, 2004·Controlled Clinical Trials·A John RushUNKNOWN STAR*D Investigators Group
May 26, 2004·Journal of Behavior Therapy and Experimental Psychiatry·T Sheeran, M Zimmerman
May 17, 2005·Journal of Affective Disorders·A John RushMadhukar H Trivedi
Jul 14, 2005·Journal of Clinical Psychopharmacology·Arif KhanWalter A Brown
Jan 5, 2006·The American Journal of Psychiatry·Madhukar H TrivediUNKNOWN STAR*D Study Team
Oct 21, 2006·Current Opinion in Pulmonary Medicine·Vidya Krishnan, Nancy A Collop
Mar 12, 2008·Developmental Psychology·Stephanie T Lanza, Linda M Collins
Aug 30, 2008·Journal of Psychiatric Research·Elizabeth A YoungA John Rush
Apr 3, 2009·The American Journal of Psychiatry·Stephen R WisniewskiMadhukar H Trivedi
May 30, 2009·The British Journal of Psychiatry : the Journal of Mental Science·Lindsey I SinclairSimon J C Davies
Jun 30, 2009·Pharmacotherapy·Kelan L H Thomas, Vicki L Ellingrod
Nov 4, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Jeylan S BuyukduraPaul E Croarkin
Feb 25, 2011·Journal of Clinical Psychopharmacology·Shawn M McClintockAugustus John Rush
Aug 16, 2011·Acta Psychiatrica Scandinavica·S D OstergaardP Bech
Feb 22, 2012·Psychological Medicine·F LamersB W J H Penninx
May 7, 2013·Behaviour Research and Therapy·Jay C FournierJay D Amsterdam
Dec 3, 2013·European Archives of Psychiatry and Clinical Neuroscience·Stephanie RodgersWulf Rössler
Jan 7, 2014·Journal of Affective Disorders·Jérôme J J SchuchPeter de Jonge
Feb 15, 2014·The American Journal of Psychiatry·Kenneth S Kendler, Charles O Gardner
Apr 2, 2014·The American Journal of Psychiatry·Thomas R Insel
Jun 21, 2014·Current Medical Research and Opinion·M FergusonS R Wisniewski
Dec 3, 2014·Journal of Affective Disorders·Eiko I Fried, Randolph M Nesse
Oct 7, 2015·American Journal of Men's Health·Christine M UlbrichtKate L Lapane
Nov 26, 2015·The Psychiatric Clinics of North America·Meredith E RumbleRuth M Benca

❮ Previous
Next ❯

Citations

Oct 17, 2018·Psychological Medicine·S WaltherS A Shankman
Nov 9, 2016·Molecular Psychiatry·H M van LooE I Fried
Jul 20, 2020·Hormones and Behavior·Susana Barbosa-MéndezAlberto Salazar-Juárez
May 8, 2021·Depression and Anxiety·Melanie Simmonds-BuckleyJaime Delgadillo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.